E-drug: Training workshop on writing about medicines for people
-------------------------------------------------------------------------
In connection with the FIP Congress in Sydney September this
year, the Pharmacy Information Section of FIP in conjunction with
the Medicines Labelling Group will organize a Two-Day
Pre-Conference Satellite Training Workshop on Writing about
Medicines for People. This will be run by Prof David Sless and
Alex Tyers.
David Sless Director of CRIA, Communication Research Institute
of Australia is a world authority in developing principles for writing
useable information on medicines .
http://www.communication.org.au/
A full description of the programme is presented below.
Those who are interested can contact:
Jerome Reinstein
Co-Facilitator Medicines Labelling Group
Tel +44 (0)20 8994 2890
Fax +44 (0)20 8995 0915
jeromereinstein@compuserve.com
or
Yong Kwok
Co-Facilitator Medicines Labelling Group
Tel +1 212 517 4713
Fax +1 212 772 8527
YKwok123@aol.com
The Medicines Labelling Group is a diverse group of individuals
with experience in consumer advocacy, pharmaceutical industry,
medicine and NGO's concerned with health. They work together
to improve the usefulness of labels and leaflets.
Best regards,
Stein Lyftingsmo
Hospital Pharmacy of Elverum, Norway
stein@lyftingsmo.no
www.lyftingsmo.no
************************************************** >
Training workshop on Writing about Medicines for People
Joint session of the Communication Research Institute of
Australia (CRIA), the Medicines Labelling Group, Pharmacy
Information Section, FIP
FIP Conference, September 3-4, 2003, Sydney, Australia
Facilitated by Professor David Sless, Director, CRIA and Alex
Tyers, CRIA The two-day training workshop will introduce
participants to the principles and procedures for creating usable
medicines information for people.
Day 1 will be devoted to examining the background to the
controversial nature of controlling medicines information
throughout the world. The tensions and conflicts that are evident
in the provision of information will be discussed. These arise out of
product liability issues, marketing goals of manufacturers along
with manufacturers need to have their products used safely and
appropriately and the duty of care obligations on the part of health
professionals. Consumers perspective, their needs and wants on
medicines information, add to these complex issues. Different
regulatory approaches to improving medicines information,
notably the Australian, American and European, will be shared
with demonstration and discussion of real life examples of label
usability improvement using principles of information design. In
particular, the performance based approach to writing about
medicines for people as developed by the Communication
Research Institute of Australia will be introduced. CRIA's
extensive research and their application in meeting users needs
and wants for appropriate and effective use of medicines including
both prescription and non-prescription drugs will be covered.
Principles, standard setting of the performance-based approach
and their potential application in different cultures will be
discussed.
Day 2 will be in two breakout groups; one for the regulators and
would-be writers of medicines information mostly from industry,
the other will be for practising pharmacists. The regulators and
writers workshop will cover the skills and processes needed to
developing medicines information for people. These will involve
identifying the objectives in medicines labelling, how to achieve
those objectives including the role of different stakeholders, costs,
location of labelling design in drug companies. The participants
will work with the trainers to gain in-depth understanding of
procedures and processes needed for producing effective labels
and leaflets. The workshop for practising pharmacists will examine
how the availability of user-friendly labels and leaflets can improve
and enhance their professional duty of care. Both academics and
practising pharmacists will discuss the role of information in
complying with professional standards on counselling patients on
medicines. Different categories of medicines with their associated
risks will be given particular attention. Two well-know Australian
pharmacists who have been especially active in the development
of patient counselling on medicines have also been invited to take
part.
Fee for both days is A$160 (US$160). Some support and waiver
of fees is available for those from developing countries who
require additional funding in order to attend.
--
To send a message to E-Drug, write to: e-drug@usa.healthnet.org
To subscribe or unsubscribe, write to: majordomo@usa.healthnet.org
in the body of the message type: subscribe e-drug OR unsubscribe e-drug
To contact a person, send a message to: e-drug-help@usa.healthnet.org
Information and archives: http://www.essentialdrugs.org/edrug